Affiliation:
1. Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA
Abstract
Abstract
The liver is the most common site of distant metastasis from colorectal cancer. About one-fourth of patients with liver metastases from colorectal cancer have no other sites of metastasis and can be treated with regional therapies directed toward their liver tumors. Surgical resection of colorectal cancer liver metastases can result in a 24%-38% five-year survival, but only a minority of patients are candidates for resection. Other regional therapies such as cryosurgery, radiofrequency ablation, and hepatic intra-arterial chemotherapy may be offered to patients with unresectable but isolated liver metastases. The efficacy of these treatments is still being determined. For most patients with spread of metastatic colorectal cancer beyond the liver, systemic chemotherapy rather than regional therapy is a more appropriate option.
Publisher
Oxford University Press (OUP)
Reference102 articles.
1. Cancer statistics, 1998;Landis;CA Cancer J Clin,1998
2. Surgical treatment of liver metastases in patients with colorectal cancer;Ballantyne;Cancer,1993
3. Treatment of metastatic disease of the liver: a skeptic's view;Foster;Semin Liver Dis,1984
4. Long-term survival after hepatic cryosurgery versus surgical resection for metastatic colorectal carcinoma: a critical review of the literature;Tandan;Can J Surg,1997
5. Hepatic resection for metastases from colorectal carcinoma is of dubious value;Silen;Arch Surg,1989
Cited by
86 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献